Effect of menopausal hormone therapy on components of the metabolic syndrome | Zendy

Dragana Lovre | Zendy; Sarah H. Lindsey | Zendy; Franck MauvaisJarvis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of menopausal hormone therapy on components of the metabolic syndrome

Author(s) -

Dragana Lovre,

Sarah H. Lindsey,

Franck MauvaisJarvis

Publication year - 2016

Publication title -

therapeutic advances in cardiovascular disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.164

H-Index - 33

eISSN - 1753-9455

pISSN - 1753-9447

DOI - 10.1177/1753944716649358

Subject(s) - medicine , metabolic syndrome , dyslipidemia , menopause , lifestyle modification , type 2 diabetes , obesity , hormone therapy , endocrinology , diabetes mellitus , hormone replacement therapy (female to male) , hormone , bioinformatics , physiology , testosterone (patch) , cancer , biology , breast cancer

The world population is aging, and women will spend an increasing share of their lives in a postmenopausal state that predisposes to metabolic dysfunction. Thus, the prevalence of metabolic syndrome (MetS) in women is likely to increase dramatically. This article summarizes the effects of menopause in predisposing to components of MetS including visceral obesity, dyslipidemia, type 2 diabetes (T2D) and hypertension (HTN). We also summarize the effects of menopausal hormone therapy (MHT) in reversing these metabolic alterations and discuss therapeutic advances of novel menopausal treatment on metabolic function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research